Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
08:00am, Monday, 10'th Jun 2024
Abbott Laboratories gained U.S. clearance Monday for a pair of new CGMs. The news could push Abbott stock closer to a breakout.
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
08:00am, Monday, 10'th Jun 2024
Abbott's consumer biowearable, Lingo™, is designed for general consumers who are looking to improve their overall health and wellness Libre Rio™ is designed for adults with Type 2 diabetes who do
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
07:10am, Friday, 07'th Jun 2024
From 1930 to 2023, 70% of dividend stocks in the top two quintiles outperformed the S&P 500 during recessions. Dividends have contributed 40% of the stock market gain since 1930, increasing with risin
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
10:31am, Thursday, 06'th Jun 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Abbott (ABT) Stock Dips While Market Gains: Key Facts
06:51pm, Wednesday, 05'th Jun 2024
In the closing of the recent trading day, Abbott (ABT) stood at $103.23, denoting a -0.19% change from the preceding trading day.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 05'th Jun 2024
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
The 2 Most Important Charts I Want (Dividend) Investors To See
07:30am, Wednesday, 05'th Jun 2024
Recent data indicates a heightened risk of stagflation, with slowing economic growth and persistent inflation. This poses challenges for the economy and portfolios, but also presents opportunities to
Abbott Laboratories: Why I Agree With Wall Street On This One
12:39am, Tuesday, 04'th Jun 2024
Wall Street analysts have a 'strong buy' rating on ABT stock, with 12 out of 24 analysts giving it this rating in the last 90 days. We agree with such bullish sentiment. Despite some risks, ABT stock
Tecarfarin, which recently received Orphan Drug Designation from the FDA for the prevention of thromboembolism and thrombosis in patients with an implanted mechanical circulatory support device, has t
Abbott (ABT) Rises As Market Takes a Dip: Key Facts
06:51pm, Thursday, 30'th May 2024
The latest trading day saw Abbott (ABT) settling at $101.74, representing a +1% change from its previous close.
Calls Of The Day: Eli Lilly, UnitedHealth Group, Abbott Labs and Johnson & Johnson
01:47pm, Thursday, 30'th May 2024
The Investment Committee discuss the latest Calls of the Day.
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024
06:45am, Tuesday, 28'th May 2024
Healthcare stocks to buy are booming in the U.S. due to the nation's aging population. Spending on healthcare in the U.S. now totals $4.4 trillion, or $13,493 per person, each year — more than any o
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market
12:46pm, Monday, 27'th May 2024
Earlier, the Federal Reserve stood poised to cut the benchmark interest rate, which boded well for reliable dividend stocks. Essentially, Uncle Sam's high yields wouldn't compete with the passive inco
Blue-Chip Bonanza: 3 Stocks to Ride the Market's Coattails to Riches
12:39pm, Monday, 27'th May 2024
The bull market continues; markets quickly dusted off the 5% correction in April and soared to new highs. With too much cash on the sidelines, every shallow correction has become a buying opportunity.
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
06:51pm, Friday, 24'th May 2024
Abbott (ABT) concluded the recent trading session at $103.95, signifying a -0.27% move from its prior day's close.
